| Basics |
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals PLC is a biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
|
| IPO Date: |
June 1, 2007 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$10.31B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.42 | 1.98%
|
| Avg Daily Range (30 D): |
$2.15 | 1.37%
|
| Avg Daily Range (90 D): |
$1.76 | 1.29%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.58M |
| Avg Daily Volume (30 D): |
1.1M |
| Avg Daily Volume (90 D): |
.76M |
| Trade Size |
| Avg Trade Size (Sh.): |
82 |
| Avg Trade Size (Sh.) (30 D): |
51 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Inst.Trades: |
10,131 |
| Avg Inst. Trade: |
$4.66M |
| Avg Inst. Trade (30 D): |
$6.24M |
| Avg Inst. Trade (90 D): |
$6.87M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.96M |
| Avg Closing Trade (30 D): |
$17.66M |
| Avg Closing Trade (90 D): |
$15.98M |
| Avg Closing Volume: |
61.46K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-6.01
|
$4.14
|
$-11.74
|
|
Diluted EPS
|
$-6.18
|
$4.08
|
$-11.74
|
|
Revenue
|
$ 4.16B
|
$ 1.13B
|
$ 1.05B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -368.48M
|
$ 251.41M
|
$ -718.47M
|
|
Operating Income / Loss
|
$ -494.01M
|
$ 57.51M
|
$ -686.39M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -892.07M
|
$ 136.19M
|
$ -672.07M
|
|
PE Ratio
|
|
|
|
|
|
|
